Literature DB >> 15871884

Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.

Farrah Ibrahim J Al-Tureihi1, Ali Hassoun, Gisele Wolf-Klein, Henry Isenberg.   

Abstract

OBJECTIVES: To identify risk factors for Clostridium difficile-associated disease (CDAD) in nursing home patients.
DESIGN: Retrospective chart reviews.
SETTING: Long-term care facility with 347 beds and an additional 180 sub-acute care beds, adjacent to an academic tertiary care hospital center. PARTICIPANTS: Twenty-five patients had documented diagnosis of CDAD. Eighty-four percent were female, 76% white, 16% black, 4% Asian, and 4% Hispanic. Age ranged between 60 and 97 years (mean: 82.2 years). The control group had 28 patients, 68% were female, 89% white, and 11% black. Age ranged between 61 and 101 years (mean: 82.3 years). MEASUREMENTS: Length of stay at the facility, initial presenting symptoms, white blood cell count at the time of diagnosis, serum albumin level prior to the start of antibiotics, body mass index calculated from weight and height, presence or absence of dementia, history of diabetes mellitus and colonic disease, activity of daily living data include mobility, toileting and eating, use of percutaneous enterogastrostomy feeding, antibiotic administration, namely, type and duration, use of enema and laxatives, and use of proton pump inhibitors.
RESULTS: Episodes of CDAD occurred mainly within the first year of admission to our facility, with a mean of 6 months, whereas the mean length of stay was 25 months in the control group (t = 3.452; df = 51; P < .01). Albumin level was another major risk factor for CDAD, with an overwhelming 68% of CDAD patients having albumin levels below 3 g/dL (mean 2.68 g/dL) compared with a mean of 3.22 g/dL in the control group (t = 4.210; df = 51; P < .001). The third significant risk factor was the use of proton pump inhibitors, 60% versus 32%, respectively (chi(2) = 4.137; df = 1; P < .05). Levofloxacin was the most frequently prescribed antibiotic (37%). Surprisingly, factors not associated with CDAD included dementia, diabetes mellitus, colonic disease, use of enema, use of laxatives, weight and body metabolic index, duration of previous antibiotic therapy for unrelated infection, mobility, toileting, and method of eating.
CONCLUSION: A low albumin level, a recent admission to a nursing facility, and the use of proton pump inhibitors should be considered as probable risk factors for CDAD when assessing institutionalized patients with diarrhea. These findings may facilitate the timely and efficient management of CDAD in nursing home patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871884     DOI: 10.1016/j.jamda.2005.01.003

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  31 in total

Review 1.  Safety of the long-term use of proton pump inhibitors.

Authors:  Alan B R Thomson; Michel D Sauve; Narmin Kassam; Holly Kamitakahara
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

2.  Does PPI therapy predispose to Clostridium difficile infection?

Authors:  Chaitanya Pant; Phillip Madonia; Anil Minocha
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

3.  Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.

Authors:  I Vesteinsdottir; S Gudlaugsdottir; R Einarsdottir; E Kalaitzakis; O Sigurdardottir; E S Bjornsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-23       Impact factor: 3.267

4.  Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.

Authors:  Kate N Wang; J Simon Bell; Edwin C K Tan; Julia F M Gilmartin-Thomas; Michael J Dooley; Jenni Ilomäki
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

5.  Clostridium difficile in the Long-Term Care Facility: Prevention and Management.

Authors:  Robin L P Jump; Curtis J Donskey
Journal:  Curr Geriatr Rep       Date:  2015-03

6.  Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).

Authors:  Stefano Di Bella; Alexander W Friedrich; Esther García-Almodóvar; Maria Serena Gallone; Fabrizio Taglietti; Simone Topino; Vincenzo Galati; Emma Johnson; Silvia D'Arezzo; Nicola Petrosillo
Journal:  BMC Infect Dis       Date:  2015-04-22       Impact factor: 3.090

Review 7.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

8.  Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection.

Authors:  Michelle M Nerandzic; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

Review 9.  A review of the economics of treating Clostridium difficile infection.

Authors:  Kari A Mergenhagen; Amy L Wojciechowski; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

10.  Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.

Authors:  Vanessa Arriola; Jessica Tischendorf; Jackson Musuuza; Anna Barker; Jeffrey W Rozelle; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-28       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.